Identifying future models for delivering genetic services: a nominal group study in primary care.
Identifying future models for delivering genetic services: a nominal group study in primary care.
复制标题
DOI：
10.1186/1471-2296-6-14
复制
发表时间：
2005-04-14
影响因子：
2.9
通讯作者：
Gray, Jonathon
中科院分区：
文献类型：
--
作者：
Elwyn, Glyn;Edwards, Adrian;Gray, Jonathon
背景技术背景：为了使初级保健医生产生一系列可能的服务提供模式的遗传咨询service.METHODS：修改名义组技术在初级保健专业发展workshops.RESULTS：37全科医生在威尔士，英国也在名义组过程中的一部分。与会的从业人员认为，目前的系统不足以满足预期的遗传服务需求。与会者提出了各种不同的服务模式，但没有一个单一的备选方案可以作为明确的优先选择。没有人认为遗传评估和咨询是家庭实践的核心，也没有人认为家庭医生应该熟练地向患者提供有关预测性基因检测的建议，并能够就基因检测对患者及其家庭成员的更广泛影响向患者提供咨询，即使是在常见癌症等领域。尽管如此，所有的首选模式都高度重视在社区提供的服务，并往往共同定位在初级保健，由临床医生谁开发的专业知识.CONCLUSION：有必要进行更广泛的辩论，医疗保健系统如何解决个人对遗传问题和风险的关注，特别是考虑到越来越多的商业营销的基因检测。
BACKGROUND: To enable primary care medical practitioners to generate a range of possible service delivery models for genetic counselling services and critically assess their suitability.METHODS: Modified nominal group technique using in primary care professional development workshops.RESULTS: 37 general practitioners in Wales, United Kingdom too part in the nominal group process. The practitioners who attended did not believe current systems were sufficient to meet anticipated demand for genetic services. A wide range of different service models was proposed, although no single option emerged as a clear preference. No argument was put forward for genetic assessment and counselling being central to family practice, neither was there a voice for the view that the family doctor should become skilled at advising patients about predictive genetic testing and be able to counsel patients about the wider implications of genetic testing for patients and their family members, even for areas such as common cancers. Nevertheless, all the preferred models put a high priority on providing the service in the community, and often co-located in primary care, by clinicians who had developed expertise.CONCLUSION: There is a need for a wider debate about how healthcare systems address individual concerns about genetic concerns and risk, especially given the increasing commercial marketing of genetic tests.